Curvebeam AI Ltd. (AU:CVB) has released an update.
CurveBeam AI Ltd. has announced an adjustment to the exercise price of certain options following a recent entitlement offer, in compliance with ASX Listing Rule 6.22. The adjustment affects over 12 million Noteholder Options and around 16 million Plan Options, with new exercise prices set to take effect from 12 September 2024. CurveBeam AI specializes in medical imaging CT scanners and AI-based clinical assessment tools, with a global presence and its flagship CT scanner HiRise.
For further insights into AU:CVB stock, check out TipRanks’ Stock Analysis page.
